Heterotopic heart transplantation is an alternative option in end-stage heart disease. We present a patient with a heterotopic allograft that maintained hemodynamics at the period of a malignant ventricular dysrhythmia and supports the notion that these otherwise lethal dysrhythmias of the native heart may not carry the same risk of sudden heart death in patients with heterotopic heart transplantation.